On Jan. 12, LinnCo, LLC (Nasdaq:LNCO) and Linn Energy, LLC (NASDAQ:LINE) announced the estimated federal income tax characteristics of its 2014 cash distributions to holders of its common shares and estimated 2014 and 2015 LinnCo cash tax liability. On Monday shares of Linn Energy, LLC (NASDAQ:LINE) closed at $10.14. Company’s sales growth for last 5 years was 10.20% and EPS growth for next 5 years is recorded as -14.50%.
Annaly Capital Management (NYSE:NLY) has earned a consensus recommendation of “Hold” from the ten analysts that are presently covering the stock, American Banking News.com reports. One analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and two have given a buy recommendation to the company. Annaly Capital Management, Inc. (NYSE:NLY) in last trading activity moved up 1.14% to close at $10.67. Company weekly performance is 0.57% while its quarterly performance stands at -2.91%. Annaly Capital Management, Inc. (NYSE:NLY) is -5.91% away from its 52 week high.
On Jan 22, Cvent, Inc. (NYSE:CVT) announced the date and location of Cvent Connect. The company will be hosting three conferences at the same time during the span of a week. The five day event will take place in Las Vegas from June 14-18 at the MGM Grand Hotel & Casino. On last trading day Cvent, Inc. (NYSE:CVT) decreased -1.82% to close at $27.03. Its volatility for the week is 2.71% while volatility for the month is 2.62%. CVT’s sales growth for past 5 years was 33.60% and its EPS growth for past 5 years was -29.40%. Cvent, Inc. (NYSE:CVT) monthly performance is -1.35%.
On Jan. 12, The India Fund, Inc. (NYSE:IFN) announced that it paid on January 12, 2015, a distribution of US$1.73515 per share to all shareholders of record as of December 31, 2014. The India Fund, Inc. (NYSE:IFN) has institutional ownership stands at 23.20%. In last trading activity company’s stock closed at $29.64.
Merck & Co. Inc. (NYSE:MRK) announced that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of the investigational antibiotic SIVEXTRO (tedizolid phosphate) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults. On Monday shares of Merck & Co. Inc. (NYSE:MRK) closed at $62.82. Company’s sales growth for last 5 years was 13.00% and EPS growth for next 5 years is recorded as 5.86%.